| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting
|
Cordell, Cyndy B.
|
|
2013
|
9 |
2 |
p. 141-150
10 p.
|
article
|
| 2 |
Alzheimer's Association Update
|
|
|
2013
|
9 |
2 |
p. 246-249
4 p.
|
article
|
| 3 |
2013 Alzheimer's disease facts and figures
|
|
|
2013
|
9 |
2 |
p. 208-245
38 p.
|
article
|
| 4 |
Amyloid imaging and cognitive decline in nondemented oldest-old: The 90+ Study
|
Kawas, Claudia H.
|
|
2013
|
9 |
2 |
p. 199-203
5 p.
|
article
|
| 5 |
Butyrylcholinesterase genotype and gender influence Alzheimer’s disease phenotype
|
Lane, Roger M.
|
|
2013
|
9 |
2 |
p. e17-e73
nvt p.
|
article
|
| 6 |
Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease
|
Carrillo, Maria C.
|
|
2013
|
9 |
2 |
p. 123-131.e1
1188 p.
|
article
|
| 7 |
Contents
|
|
|
2013
|
9 |
2 |
p. A1-A2
nvt p.
|
article
|
| 8 |
Current knowledge and future directions about the disclosure of dementia: A systematic review of the first decade of the 21st century
|
Werner, Perla
|
|
2013
|
9 |
2 |
p. e74-e88
nvt p.
|
article
|
| 9 |
Editorial Board
|
|
|
2013
|
9 |
2 |
p. A5-
1 p.
|
article
|
| 10 |
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging
|
Solfrizzi, Vincenzo
|
|
2013
|
9 |
2 |
p. 113-122
10 p.
|
article
|
| 11 |
Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development
|
Boxer, Adam L.
|
|
2013
|
9 |
2 |
p. 176-188
13 p.
|
article
|
| 12 |
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium
|
Carrillo, Maria C.
|
|
2013
|
9 |
2 |
p. 137-140
4 p.
|
article
|
| 13 |
Improving dementia care: The role of screening and detection of cognitive impairment
|
Borson, Soo
|
|
2013
|
9 |
2 |
p. 151-159
9 p.
|
article
|
| 14 |
Intracerebral propagation of Alzheimer’s disease: Strengthening evidence of a herpes simplex virus etiology
|
Ball, Melvyn J.
|
|
2013
|
9 |
2 |
p. 169-175
7 p.
|
article
|
| 15 |
Medical and Scientific Advisory Council
|
|
|
2013
|
9 |
2 |
p. A6-
1 p.
|
article
|
| 16 |
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
|
Yang, Ting
|
|
2013
|
9 |
2 |
p. 99-112
14 p.
|
article
|
| 17 |
Predictors of progression to severe Alzheimer’s disease in an incidence sample
|
Rabins, Peter V.
|
|
2013
|
9 |
2 |
p. 204-207
4 p.
|
article
|
| 18 |
Research and standardization in Alzheimer's trials: Reaching international consensus
|
Carrillo, Maria C.
|
|
2013
|
9 |
2 |
p. 160-168
9 p.
|
article
|
| 19 |
Subscriber information
|
|
|
2013
|
9 |
2 |
p. A7-
1 p.
|
article
|
| 20 |
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)
|
Boxer, Adam L.
|
|
2013
|
9 |
2 |
p. 189-198
10 p.
|
article
|
| 21 |
TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial
|
Roses, Allen D.
|
|
2013
|
9 |
2 |
p. 132-136
5 p.
|
article
|
Journal description